Cytomegalovirus infections in cancer patients receiving granulocyte transfusions [6]

Blood

Volumn 99, Issue 9, 2002, Pages 3483-3484

  Nichols, W Garrett ^a   Price, Thomas ^a   Boeckh, Michael ^a  

^a Fred Hutchinson Cancer Research Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; FLUDARABINE; GRANULOCYTE COLONY STIMULATING FACTOR; STEROID;

BLOOD BANK; BLOOD COMPONENT THERAPY; BLOOD DONOR; CANCER PATIENT; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; GRANULOCYTE TRANSFUSION; HIGH RISK POPULATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFECTION RISK; LETTER; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SCREENING; SEROPREVALENCE; STEM CELL TRANSPLANTATION; VIRUS TRANSMISSION;

EID: 0036566624     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.V99.9.3483     Document Type: Letter

References (10)

1. Granulocyte transfusions
2. Cytomegalovirus infections in cancer patients receiving granulocyte transfusions
3. The effect of granulocyte transfusions on the incidence of cytomegalovirus infection after allogeneic marrow transplantation
4. Prevention of cytomegalovirus infection by cytomegalovirus immune globulin after marrow transplantation
5. Cytomegalovirus infection after marrow transplantation for aplastic anemia
6. Prophylactic granulocyte transfusions during human bone marrow transplantation
7. Cytomegalovirus pneumonia in adults with leukemia: An emerging problem
8. Increased transplant-related morbidity and mortality in CMV-seropositive patients despite highly effective prevention of CMV disease after allogeneic T-cell depleted stem cell transplantation
9. Community donors vs related donors for granulocyte transfusion therapy in hematopoietic transplantation: A comparative analysis of feasibility and outcome
10. Therapeutic granulocyte transfusions: Retrospective study of 34 patients